These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 6100061)

  • 1. Immune response induced by live attenuated varicella vaccine and short term follow-up on immunity of the vaccinated children.
    Chiba Y; Miura J; Kumagai T; Nakao T
    Biken J; 1984 Sep; 27(2-3):67-71. PubMed ID: 6100061
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Humoral and cellular immune response to varicella-zoster virus in children inoculated with live attenuated varicella vaccine.
    Kumagai T; Chiba Y; Fujiwara M; Hanazono H; Nakamura S; Chiba S; Nakao T; Takahashi M
    Biken J; 1980 Sep; 23(3):135-41. PubMed ID: 6257227
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A live varicella vaccine in a pediatric community.
    Yabuuchi H; Baba K; Tsuda N; Okada S; Nose O; Seino Y; Tomita K; Ha K; Mimaki T; Ogawa M
    Biken J; 1984 Sep; 27(2-3):43-9. PubMed ID: 6100057
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical trial of the Oka strain of live attenuated varicella vaccine on healthy children.
    Ozaki T; Matsui T; Ichikawa T; Asano Y; Yamanishi K; Takahashi M
    Biken J; 1984 Sep; 27(2-3):39-42. PubMed ID: 6100056
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical application of a live varicella vaccine (Oka strain) in a hospital.
    Naganuma Y; Osawa S; Takahashi R
    Biken J; 1984 Sep; 27(2-3):59-61. PubMed ID: 6100059
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Varicella vaccination in HIV-1-infected children after immune reconstitution.
    Bekker V; Westerlaken GH; Scherpbier H; Alders S; Zaaijer H; van Baarle D; Kuijpers T
    AIDS; 2006 Nov; 20(18):2321-9. PubMed ID: 17117018
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The incidence of zoster after immunization with live attenuated varicella vaccine. A study in children with leukemia. Varicella Vaccine Collaborative Study Group.
    Hardy I; Gershon AA; Steinberg SP; LaRussa P
    N Engl J Med; 1991 Nov; 325(22):1545-50. PubMed ID: 1658650
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Experience and reason: twenty-year follow-up of protective immunity of the Oka strain live varicella vaccine.
    Asano Y; Suga S; Yoshikawa T; Kobayashi I; Yazaki T; Shibata M; Tsuzuki K; Ito S
    Pediatrics; 1994 Oct; 94(4 Pt 1):524-6. PubMed ID: 7936864
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect and follow-up study on varicella vaccine.
    Katsushima N; Yazaki N; Sakamoto M
    Biken J; 1984 Sep; 27(2-3):51-8. PubMed ID: 6100058
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Live attenuated varicella vaccine: the KMcC strain in healthy children.
    Arbeter AM; Starr SE; Weibel RE; Neff BJ; Plotkin SA
    Pediatrics; 1983 Mar; 71(3):307-12. PubMed ID: 6298698
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunogenicity of a two-dose regime of varicella vaccine in children with cancers.
    Leung TF; Li CK; Hung EC; Chan PK; Mo CW; Wong RP; Chik KW
    Eur J Haematol; 2004 May; 72(5):353-7. PubMed ID: 15059071
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A five-year immunological follow-up study of the institutionalized handicapped children vaccinated with live varicella vaccine or infected with natural varicella.
    Ueda K; Tokugawa K; Nakashima F; Takahashi M
    Biken J; 1984 Sep; 27(2-3):119-22. PubMed ID: 6100048
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical experience with Oka live varicella vaccine in Japan.
    Takahashi M; Kamiya H; Baba K; Asano Y; Ozaki T; Horiuchi K
    Postgrad Med J; 1985; 61 Suppl 4():61-7. PubMed ID: 3014479
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A clinical trial of live attenuated varicella vaccine (Biken) in children with malignant diseases.
    Konno T; Yamaguchi Y; Minegishi M; Goto Y; Tsuchiya S
    Biken J; 1984 Sep; 27(2-3):73-5. PubMed ID: 6100062
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term protective immunity of recipients of the OKA strain of live varicella vaccine.
    Asano Y; Nagai T; Miyata T; Yazaki T; Ito S; Yamanishi K; Takahashi M
    Pediatrics; 1985 Apr; 75(4):667-71. PubMed ID: 2984636
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Live varicella vaccine: prevention of nosocomial infection and protection of high risk infants from varicella infection.
    Sugino H; Tsukino R; Miyashiro E; Dezawa T; Shinohara K; Uemura S; Koike M
    Biken J; 1984 Sep; 27(2-3):63-5. PubMed ID: 6100060
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Application of a live varicella vaccine to hospitalized children and its follow-up study.
    Katsushima N; Yazaki N; Sakamoto M; Fujiyama J; Nakagawa M; Okuyama Y; Takahashi M
    Biken J; 1982 Mar; 25(1):29-42. PubMed ID: 6289798
    [No Abstract]   [Full Text] [Related]  

  • 18. Persistence of protective immunity after inoculation with live varicella vaccine (strain Oka).
    Asano Y; Nagai T; Miyata T; Yazaki T; Ito S; Yamanishi K; Takahashi M
    Biken J; 1984 Sep; 27(2-3):123-8. PubMed ID: 6100049
    [No Abstract]   [Full Text] [Related]  

  • 19. Five-year follow-up study of recipients of live varicella vaccine using enhanced neutralization and fluorescent antibody membrane antigen assays.
    Asano Y; Albrecht P; Vujcic LK; Quinnan GV; Kawakami K; Takahashi M
    Pediatrics; 1983 Sep; 72(3):291-4. PubMed ID: 6310478
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical and serologic testing of a live varicella vaccine and two-year follow-up for immunity of the vaccinated children.
    Asano Y; Takahashi M
    Pediatrics; 1977 Dec; 60(6):810-4. PubMed ID: 202916
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.